Alloy Therapeutics IPO

Alloy Therapeutics is a biotech ecosystem company, facilitating affordable, non-exclusive access to the entire drug discovery community from academic scientists, small and medium biotech, to the largest biopharma. The company's platform is a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains.

Register for Details

For more details on financing and valuation for Alloy Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Alloy Therapeutics's ticker symbol?

Alloy Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Alloy Therapeutics's stock price?

The stock price for Alloy Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are Alloy Therapeutics's major investors?

8VC
Founders Fund
Mubadala Capital Ventures

Alloy Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
10/3/2022 Series D $736.24MM $XXX.XX $XXX.XX
4/2/2021 Series C $563.04MM $XXX.XX $XXX.XX
5/31/2020 Series B $91.25MM $XXX.XX $XXX.XX
4/13/2020 Series A-1, A-2, and A-3 $37.31MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Alloy Therapeutics

What is Alloy Therapeutics funding to date?

Alloy Therapeutics has raised $136.24MM with the following series:
$37.31MM for Series A-1, A-2, and A-3, $91.25MM for Series B, $563.04MM for Series C, $736.24MM for Series D

When was Alloy Therapeutics founded?

Alloy Therapeutics was founded in 2020.

Can you invest in Alloy Therapeutics?

Alloy Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Alloy Therapeutics share pre-IPO?

If you own Alloy Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Is Alloy Therapeutics a publicly traded company?

Alloy Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Alloy Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$327.39MM
Sector
 
 
Sector
Last Round Est. Valuation
$500MM